Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea ( 18 a topical compound based on the San...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea

18, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea and other skin disorders.

Research has shown that compounds can be created by chemically modifying certain tetracyclines and that these new compounds have properties that may make them effective in treating diseases involving inflammation and/or destruction of the body's connective tissues. CollaGenex is evaluating various chemically modified tetracyclines (so called "IMPACS" compounds because they are Inhibitors of Multiple Proteases And CytokineS") to assess whether they are safe and effective in these applications. The Company has a pipeline of innovative product candidates with possible applications in dermatology and other disease states. In addition, CollaGenex has acquired the SansRosa(TM) technology, which consists of a class of compounds that have shown promise in reducing the redness associated with rosacea, and the Restoraderm(R) technology, a unique, proprietary dermal drug delivery system. CollaGenex plans to leverage these platforms to develop a range of topical dermatological products with enhanced pharmacologic and cosmetic properties.

To receive additional information on the Company, please visit our Web site at www.collagenex.com, which does not form part of this press release.

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the Company's plans, timing and success related to its patent applications and the launch of Oracea for the treatment of inflammatory lesions of rosacea, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. CollaGenex' actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including those factors contained in the most recent Form 10-K for the yea
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
5. New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
6. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
7. King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide
8. Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for Psychotic Major Depression Misses Primary Endpoint
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

Post Your Comments:

(Date:5/22/2013)... Calif. , May 22, 2013 Rigel ... the clinical advancement of three programs in development. The ... a JAK/SYK inhibitor, R348, being developed by Rigel as ... programs are aimed at oncology targets and are being ... under development by BerGenBio AS (BerGenBio) and a ligase ...

(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, Inc. ... prescription medications to sufferers of chronic pain, announced it ... national investor relations firm, to raise its visibility and ... "Over the past year, we have proven our business ... announced plans to open two additional new pharmacies in ...

(Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...

Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4 Assured Pharmacy Hires Hayden IR 2 Assured Pharmacy Hires Hayden IR 3 WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2

[0] Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye [0] Assured Pharmacy Hires Hayden IR [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile

... 7, 2011 Talyst announces AutoPharm® Mobile, an ... The mobile application can be conveniently accessed on ... efficiency and control across the health system. ... to have real-time access to medication inventory throughout ...

... NEW YORK, Dec. 7, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p098411/Global-Microscopes-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report ... US$ Million by the following Product Segments: ...

Cached Medicine Technology:Talyst Releases AutoPharm Mobile 2 Global Microscopes Industry 2

Talyst Releases AutoPharm Mobile Global Microscopes Industry

(Date:5/21/2013)... Springs, CO (PRWEB) May 22, 2013 ... plan for better nutrition--from farmers' markets filled with whole ... consumers make the most of the season the nutrition ... a healthier lifestyle not to miss. , 1. Eating ... weather that invites shoppers to linger and explore, spring ...

(Date:5/21/2013)... May 21, 2013 Standard advice for ... and little else. However given industry’s less than exceptional ... shoppers via the internet, Consumer Mattress Reports sets out ... Choosing The Best Mattress .” , This article addresses ... and suggestions that may not be readily apparent to ...

(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 Patients ... Dental Care who have lost teeth due to gum disease ... traditional surgery for gum disease treatment with laser gum ... implants, which have the highest success rate out of all ... Procedure (LANAP) is a relatively new procedure cleared by the ...

(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...

(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions and ... hiring of new talent in several areas, including Account ... Dawn Powell has joined the organization effective April 28, ... Management in the Central Region and is based in ... client management, employee benefits, and product development experience, she ...

Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2 Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3 Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2 Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2 Health News:Glaucoma drug can cause droopy eyelids 2 Health News:New Talent Joins the HealthSmart Account Management Team 2

[0] Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring [0] Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article [0] Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA [0] Glaucoma drug can cause droopy eyelids [0] New Talent Joins the HealthSmart Account Management Team

... of extensive surgery, researchers say , THURSDAY, Aug. 13 (HealthDay ... the extent of early breast cancer may do more harm ... said this use of MRI increases the likelihood that patients ... but that this more aggressive treatment doesn,t lead to improved ...

... , , , ... Inc. (NYSE Amex: KAD ), a leading provider of home care, ... for its fiscal first quarter ended June 30, 2009. , ... revenues of $26.4 million compared with $26.8 million for the same period last ...

... LOS ANGELES, Aug. 13 From cranky bosses to incompetent ... people encounter while making their way through the typical work day ... people up a wall. , , Tanna Marshall, ... 18 years, experience as a natural health practitioner, offers a collection ...

... ... the First in Georgia to Offer Online Records and Direct E-mail Access to Doctors, a ... ... affiliated with Northside Hospital, is leading the way as one of the first physicians’ offices ...

... NES ZIONA, Israel, August 13 Following the ... NanoPass,Technologies Ltd. (NanoPass) announced today that it has successfully,developed ... effectiveness and supply of pandemic flu vaccines. , ... 11th, 2009", said Dr Yotam Levin, the,Company,s CEO, "the ...

... , SEATTLE, Aug. 13 The ... been appointed to head its new European office in London, effective ... health policy and advocacy. , , "Expanding our ... we,re very pleased that Joe will be leading this effort," said ...

MRI May Not Improve Breast Cancer Outcome Arcadia Resources Announces First Quarter Results 'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines Bill & Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office

... As part of our continued effort to standardize ... to introduce the new PowerPro® Electric II Handpiece ... single trigger handpiece, a dedicated oscillating saw, a ... to this system are features such as speed, ...

... power line from MicroAire. Our new ... electric instruments, offering the ultimate in ... has always wanted with the security ... Power Master oscillating saw, Available with ...

... Linvatec Advantage System is a full-function, ... electric handpieces for a wide range ... Bone Orthopedics, Small Bone Orthopedics, Orthopedic ... Neurosurgery, and Spine Surgery. Because it ...

... System consists of a pistol-grip handpiece available ... a wide range of couplers that can ... surgical applications., ,MicroAire SmartDriver. Modular Pistol-Grip ... with different module for drilling, pinning, cutting, ...

Medicine Products:

PowerPro® Electric II System Powermaster Oscillating Saw Advantage System Electric SmartDriver